Monte Rosa Therapeutics, Inc. short interest in 2025
In 2025, Monte Rosa Therapeutics, Inc.'s disclosed short interest ran from 14.27% of shares outstanding on 15 Jan 2025 to 12.98% on 31 Dec 2025, a change of -1.29 percentage points. The year's high was 14.50% on 15 Jul 2025 and its low 8.80% on 31 Mar 2025, averaging 12.80% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.99 days on 29 Aug 2025. Full history: Monte Rosa Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 14.27% (15 Jan 2025)
- End of year
- 12.98% (31 Dec 2025)
- Change
- -1.29 pp
- High
- 14.50% (15 Jul 2025)
- Low
- 8.80% (31 Mar 2025)
- Average
- 12.80%
- Highest days to cover
- 24.99 (29 Aug 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 14.27% | 7.45 | results (8-K) |
| 31 Jan 2025 | 13.16% | 10.66 | |
| 14 Feb 2025 | 13.08% | 21.44 | |
| 28 Feb 2025 | 13.10% | 19.07 | |
| 14 Mar 2025 | 11.46% | 11.18 | |
| 31 Mar 2025 | 8.80% | 5.43 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 12.25% | 6.96 | |
| 30 Apr 2025 | 12.81% | 14.80 | |
| 15 May 2025 | 13.65% | 23.20 | 10-Q filed, results (8-K) |
| 30 May 2025 | 13.13% | 16.44 | |
| 13 Jun 2025 | 14.42% | 20.01 | |
| 30 Jun 2025 | 14.41% | 18.79 | |
| 15 Jul 2025 | 14.50% | 23.69 | |
| 31 Jul 2025 | 14.15% | 18.03 | |
| 15 Aug 2025 | 13.47% | 20.25 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 13.34% | 24.99 | |
| 15 Sep 2025 | 13.34% | 2.40 | |
| 30 Sep 2025 | 12.68% | 5.75 | |
| 15 Oct 2025 | 13.09% | 5.96 | |
| 31 Oct 2025 | 12.27% | 7.64 | |
| 14 Nov 2025 | 11.36% | 6.80 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 10.76% | 8.62 | |
| 15 Dec 2025 | 10.75% | 9.46 | |
| 31 Dec 2025 | 12.98% | 5.79 |
See also: Monte Rosa Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.